🇺🇸 FDA
Pipeline program

SRF388

SRF388-201

Phase 2 small_molecule completed

Quick answer

SRF388 for Hepatocellular Carcinoma is a Phase 2 program (small_molecule) at Coherus Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
Coherus Oncology
Indication
Hepatocellular Carcinoma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials